European Commission Approves Cemiplimab for Recurrent/Metastatic Cervical Cancer

Press/Media

Period	23 Nov 2022

Media coverage

Title	European Commission Approves Cemiplimab for Recurrent/Metastatic Cervical Cancer
Media name/outlet	Cancernetwork.com
Country/Territory	United States
Date	23/11/22
URL	ct.moreover.com/?a=49331118677&p=1gw&v=1&x=2bwfemQ_Mo0za-yKM1BJCQ
Persons	Israel Lowy,